GPT and metabolic dysfunction-associated steatotic liver disease: Recent studies with NAFLD patients have shown that the usage of ALT and AST levels is not appropriate to screen for the presence of hepatic fibrosis, however, because transaminase levels are often normal in patients with such histological changes [51–54].